CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 109 enrolled
Drug / intervention
pediatric AIHother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04247490
NCT04247490N/ACompleted
CompareCT.gov

Multicentric Study on the Long-term Follow-up of Autoimmune Hepatitis in the Pediatric Patients

University Hospital of Ferrara·observational·Posted Jan 30, 2020·Updated Jan 30, 2020

In Brief

An observational study evaluating pediatric AIH for Autoimmune Hepatitis. Completed, enrolled 109 participants across 1 site.

Detailed Summary

Autoimmune hepatitis (AIH) is an immune-mediated and inflammatory liver disorder. It is currently divided into types 1 and 2, differentiated and defined by the presence of specific autoantibodies. The objectives are to describe the prevalence and incidence of type 1 and 2 autoimmune hepatitis and to analyze the clinics, biochemical and histopathological profiles at diagnosis and follow-up, initial therapy, response to therapy and long-term follow-up in three Italian centers of patients with type 1 and type 2 AIH.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAutoimmune Hepatitis
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 30, 2020
Enrollment StartDec 17, 2019
Primary CompletionDec 31, 2019
TodayJul 2, 2026
Enrollment to primary: 14 daysPosted 6.4 years ago

Interventions

pediatric AIHother

pediatric patients with clinical, laboratory (transaminase and IgG increase), instrumental (ultrasound, liver biopsy) characteristics